[
    [
        {
            "time": "2020-12-29",
            "original_text": "Gold, Up, Amid Senate Delay on U.S. Stimulus Checks Increase Vote",
            "features": {
                "keywords": [
                    "Gold",
                    "Up",
                    "Senate",
                    "Delay",
                    "Stimulus",
                    "Checks"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "commodities",
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Gold, Up, Amid Senate Delay on U.S. Stimulus Checks Increase Vote",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Gains",
                    "Market",
                    "Dips"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pfizer (PFE) Gains As Market Dips: What You Should Know",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock",
            "features": {
                "keywords": [
                    "Novavax",
                    "Phase 3",
                    "Trial",
                    "Covid",
                    "Vaccine",
                    "Arcturus",
                    "Downgrades"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "European Union Set To Purchase 100M More Doses Of Pfizer COVID-19 Vaccine",
            "features": {
                "keywords": [
                    "European Union",
                    "Purchase",
                    "100M",
                    "Pfizer",
                    "COVID-19",
                    "Vaccine"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "international relations"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "European Union Set To Purchase 100M More Doses Of Pfizer COVID-19 Vaccine",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Why Arcturus Therapeutics Stock Crumbled On Its Covid Vaccine Update",
            "features": {
                "keywords": [
                    "Arcturus",
                    "Therapeutics",
                    "Stock",
                    "Crumbled",
                    "Covid",
                    "Vaccine",
                    "Update"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Why Arcturus Therapeutics Stock Crumbled On Its Covid Vaccine Update",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Top-Performing Biotech ETFs Amid the COVID-19 Crisis",
            "features": {
                "keywords": [
                    "Top-Performing",
                    "Biotech",
                    "ETFs",
                    "COVID-19",
                    "Crisis"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "false",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Top-Performing Biotech ETFs Amid the COVID-19 Crisis",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations",
            "features": {
                "keywords": [
                    "Biden",
                    "public health",
                    "experts",
                    "dismay",
                    "COVID",
                    "vaccine",
                    "rollout",
                    "expectations"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "government"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Health experts slam delayed COVID vaccine rollout in U.S. as early effort falls far short of expectations",
            "features": {
                "keywords": [
                    "Health",
                    "experts",
                    "slam",
                    "delayed",
                    "COVID",
                    "vaccine",
                    "rollout",
                    "effort",
                    "expectations"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "government"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Health experts slam delayed COVID vaccine rollout in U.S. as early effort falls far short of expectations",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Germany says it needs third COVID vaccine to make inoculation universal",
            "features": {
                "keywords": [
                    "Germany",
                    "third",
                    "COVID",
                    "vaccine",
                    "inoculation",
                    "universal"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "international relations"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Germany says it needs third COVID vaccine to make inoculation universal",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-12-29",
            "original_text": "Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021",
            "features": {
                "keywords": [
                    "Pfizer",
                    "BioNTech",
                    "supply",
                    "additional",
                    "100",
                    "million",
                    "COVID",
                    "vaccine",
                    "doses",
                    "EU"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "international relations"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false"
            },
            "scores": {
                "News_content": "Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]